The US9-Derived Protein gPTB9TM Modulates APP Processing Without Targeting Secretase Activities
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Alteration of neuronal protein processing is often associated with neurological disorders and is highly dependent on cellular protein trafficking. A prime example is the amyloidogenic processing of amyloid precursor protein (APP) in intracellular vesicles, which plays a key role in age-related cognitive impairment. Most approaches to correct this altered processing aim to limit enzymatic activities that lead to toxic products, such as protein cleavage by β-secretase and the resulting amyloid β production. A viable alternative is to direct APP to cellular compartments where non-amyloidogenic mechanisms are favored. To this end, we exploited the molecular properties of the herpes simplex virus 1 (HSV-1) transport protein US9 to guide APP interaction with preferred endogenous targets. Specifically, we generated a US9 chimeric construct that facilitates APP processing through the non-amyloidogenic pathway and tested it in primary cortical neurons. In addition to reducing amyloid β production, our approach controls other APP-dependent biochemical steps that lead to neuronal deficits, including phosphorylation of APP and tau proteins. Notably, it also promotes the release of neuroprotective soluble αAPP. In contrast to other neuroprotective strategies, these US9-driven effects rely on the activity of endogenous neuronal proteins, which lends itself well to the study of fundamental mechanisms of APP processing/trafficking. Overall, this work introduces a new method to limit APP misprocessing and its cellular consequences without directly targeting secretase activity, offering a novel tool to reduce cognitive decline in pathologies such as Alzheimer’s disease and HIV-associated neurocognitive disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“by exploiting a US9-derived protein gPTB9TM to direct APP away from BACE1 in neurons, β-secretase processing of APP is reduced without affecting physiological BACE1 activities [112].”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [112]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Synergy between amyloid-β and tau in Alzheimer’s disease
Busche, M. A., & Hyman, B. T. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0687-6 · Cited by 1,242
Trafficking and Proteolytic Processing of APP
Haass, C., Kaether, C., Thinakaran, G., & Sisodia, S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006270 · Cited by 1,075
Roles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003
APP processing in Alzheimer’s disease.
Zhang, Y.-W., Thompson, R., Zhang, H., & Xu, H. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-3 · Cited by 983
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
Kametani, F., & Hasegawa, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00025 · Cited by 836
Webster, S. J., Bachstetter, A. D., Nelson, P. T., Schmitt, F. A., & Van Eldik, L. J. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00088 · Cited by 755 · cited 1×
“Therefore, the expression of APPsw provides a well-established strategy to reproduce the amyloidogenic pathway in cellular and animal models [57].”
BackgroundThe prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein
Lu, P.-J., Wulf, G., Zhou, X. Z., Davies, P., & Lu, K. P. (1999) · Nature · doi:10.1038/21650 · Cited by 721
Not just amyloid: physiological functions of the amyloid precursor protein family
Müller, U. C., Deller, T., & Korte, M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.29 · Cited by 634 · cited 3×
“APP processing plays a central role in neuronal physiology and in several neurocognitive disorders [16, 58, 71].”
BackgroundKuhn, P., Wang, H., Dislich, B., Colombo, A., Zeitschel, U., Ellwart, J. W., Kremmer, E., Roßner, S., & Lichtenthaler, S. F. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.167 · Cited by 621 · cited 1×
“In contrast, the non-amyloidogenic pathway is initiated by the activity of an α-secretase [14], mainly ADAM10 in the brain [15], which cleaves APP between the β and γ sites and eventually reduces the accumulation of Aβ [16].”
BackgroundHaass, C., Lemere, C. A., Capell, A., Citron, M., Seubert, P., Schenk, D., Lannfelt, L., & Selkoe, D. J. (1995) · Nature Medicine · doi:10.1038/nm1295-1291 · Cited by 592 · cited 2×
“1 3 with the early emergence of AD and dramatically increase APP β-cleavage without altering APP accumulation and Aβ sequence [51, 52] (see Fig.”
Background
Research works printed but not linked: 57
- Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184–185. https://doi.org/10.1126/science.1566067 · DOI · Paper page
- Hategan A, Bianchet MA, Steiner J et al (2017) HIV Tat protein and amyloid-β peptide form multifibrillar structures that cause neurotoxicity. Nat Struct Mol Biol 24:379–386. https://doi.org/10.1038/nsmb.3379 · DOI
- Stern AL, Ghura S, Gannon PJ et al (2018) BACE1 mediates HIV-associated and excitotoxic neuronal damage through an APP-dependent mechanism. J Neurosci 38:4288–4300. https://doi.org/10.1523/JNEUROSCI.1280-17.2018 · DOI
- Sinha S, Anderson JP, Barbour R et al (1999) Purification and cloning of amyloid precursor protein b-secretase from human brain. Nature 402:4. https://doi.org/10.1038/990114 · DOI · Paper page
- Vassar R, Bennett BD, Babu-Khan S et al (1999) β-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735–741. https://doi.org/10.1126/science.286.5440.735 · DOI · Paper page
- Yan R, Bienkowski MJ, Shuck ME et al (1999) Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase activity. Nature 402:533–537. https://doi.org/10.1038/990107 · DOI · Paper page
- Kimberly WT, LaVoie MJ, Ostaszewski BL et al (2003) γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2. PNAS 100:6382–6387. https://doi.org/10.1073/pnas.1037392100 · DOI · Paper page
- Takasugi N, Tomita T, Hayashi I et al (2003) The role of presenilin cofactors in the γ-secretase complex. Nature 422:438–441. https://doi.org/10.1038/nature01506 · DOI · Paper page
- Sisodia SS (1992) Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci USA 89:6075–6079 · DOI · Paper page
- Meziane H, Dodart J-C, Mathis C et al (1998) Memory-enhancing effects of secreted forms of the -amyloid precursor protein in normal and amnestic mice. Proc Natl Acad Sci 95:12683–12688. https://doi.org/10.1073/pnas.95.21.12683 · DOI · Paper page
- Roch JM, Masliah E, Roch-Levecq AC et al (1994) Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor. PNAS 91:7450–7454. https://doi.org/10.1073/pnas.91.16.7450 · DOI · Paper page
- Ohsawa I, Takamura C, Morimoto T et al (1999) Amino-terminal region of secreted form of amyloid precursor protein stimulates proliferation of neural stem cells. Eur J Neurosci 11:1907–1913. https://doi.org/10.1046/j.1460-9568.1999.00601.x · DOI
- Hayashi Y, Kashiwagi K, Ohta J et al (1994) Alzheimer amyloid protein precursor enhances proliferation of neural stem cells from fetal rat brain. Biochem Biophys Res Commun 205:936–943. https://doi.org/10.1006/bbrc.1994.2755 · DOI
- Giliberto L, Zhou D, Weldon R et al (2008) Evidence that the amyloid beta precursor protein-intracellular domain lowers the stress threshold of neurons and has a “regulated” transcriptional role. Mol Neurodegener 3:12. https://doi.org/10.1186/1750-1326-3-12 · DOI
- Hooper NM (2005) Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein. Biochem Soc Trans 33:335–338. https://doi.org/10.1042/BST0330335 · DOI
- Koo EH, Squazzo SL (1994) Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 269:17386–17389. https://doi.org/10.1016/S0021-9258(17)32449-3 · DOI · Paper page
- Tan JZA, Gleeson PA (2019) The role of membrane trafficking in the processing of amyloid precursor protein and production of amyloid peptides in Alzheimer’s disease. Biochim Biophys Acta Biomembr 1861:697–712. https://doi.org/10.1016/j.bbamem.2018.11.013 · DOI · Paper page
- Tamayev R, Zhou D, D’Adamio L (2009) The interactome of the amyloid beta precursor protein family members is shaped by phosphorylation of their intracellular domains. Mol Neurodegener 4:28. https://doi.org/10.1186/1750-1326-4-28 · DOI · Paper page
- Borg JP, Ooi J, Levy E, Margolis B (1996) The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol 16:6229–6241. https://doi.org/10.1128/MCB.16.11.6229 · DOI · Paper page
- Pietrzik CU, Yoon I-S, Jaeger S et al (2004) FE65 Constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. J Neurosci 24:4259–4265. https://doi.org/10.1523/JNEUROSCI.5451-03.2004 · DOI · Paper page
- Roncarati R, Šestan N, Scheinfeld MH et al (2002) The γ-secretase-generated intracellular domain of β-amyloid precursor protein binds numb and inhibits notch signaling. Proc Natl Acad Sci USA 99:7102–7107. https://doi.org/10.1073/pnas.102192599 · DOI · Paper page
- Scheinfeld MH, Matsuda S, D’Adamio L (2003) JNK-interacting protein-1 promotes transcription of Aβ protein precursor but not Aβ precursor-like proteins, mechanistically different than Fe65. Proc Natl Acad Sci USA 100:1729–1734. https://doi.org/10.1073/pnas.0437908100 · DOI · Paper page
- McLoughlin DM, Miller CCJ (2008) The FE65 proteins and Alzheimer’s disease. J Neurosci Res 86:744–754. https://doi.org/10.1002/jnr.21532 · DOI
- Telese F, Bruni P, Donizetti A et al (2005) Transcription regulation by the adaptor protein Fe65 and the nucleosome assembly factor SET. EMBO Rep 6:77–82. https://doi.org/10.1038/sj.embor.7400309 · DOI
- Matrone C, Iannuzzi F, Annunziato L (2019) The Y682ENPTY687 motif of APP: progress and insights toward a targeted therapy for Alzheimer’s disease patients. Ageing Res Rev 52:120–128. https://doi.org/10.1016/j.arr.2019.04.003 · DOI
- Guénette S, Strecker P, Kins S (2017) APP protein family signaling at the synapse: insights from intracellular APP-binding proteins. Front Mol Neurosci 10. https://doi.org/10.3389/fnmol.2017.00087 · DOI
- Sullivan SE, Dillon GM, Sullivan JM, Ho A (2014) Mint proteins are required for synaptic activity-dependent amyloid precursor protein (APP) trafficking and amyloid β generation. J Biol Chem 289:15374–15383. https://doi.org/10.1074/jbc.M113.541003 · DOI · Paper page
- Suzuki T, Nakaya T (2008) Regulation of amyloid beta-protein precursor by phosphorylation and protein interactions. J Biol Chem 283:29633–29637. https://doi.org/10.1074/jbc.R800003200 · DOI
- Saito Y, Sano Y, Vassar R et al (2008) X11 proteins regulate the translocation of amyloid β-protein precursor (APP) into detergent-resistant membrane and suppress the amyloidogenic cleavage of APP by β-site-cleaving enzyme in brain. J Biol Chem 283:35763–35771. https://doi.org/10.1074/jbc.M801353200 · DOI · Paper page
- Brandimarti R, Hill GS, Geiger JD, Meucci O (2017) The lipid raft-dwelling protein US9 can be manipulated to target APP compartmentalization, APP processing, and neurodegenerative disease pathogenesis. Sci Rep 7:15103. https://doi.org/10.1038/s41598-017-15128-8 · DOI
- Brideau AD, Banfield BW, Enquist LW (1998) The Us9 gene product of pseudorabies virus, an alphaherpesvirus, is a phosphorylated, tail-anchored type II membrane protein. J Virol 72:4560–4570 · DOI
- Brideau AD, Eldridge MG, Enquist LW (2000) Directional transneuronal infection by pseudorabies virus is dependent on an acidic internalization motif in the Us9 cytoplasmic tail. J Virol 74:4549–4561 · DOI
- LaVail JH, Tauscher AN, Sucher A et al (2007) Viral regulation of the long distance axonal transport of herpes simplex virus nucleocapsid. Neuroscience 146:974–985. https://doi.org/10.1016/j.neuroscience.2007.02.010 · DOI
- Wisner TW, Sugimoto K, Howard PW et al (2011) Anterograde transport of herpes simplex virus capsids in neurons by both separate and married mechanisms. J Virol 85:5919–5928. https://doi.org/10.1128/JVI.00116-11 · DOI
- Pedrazzi M, Nash B, Meucci O, Brandimarti R (2014) Molecular features contributing to virus-independent intracellular localization and dynamic behavior of the herpesvirus transport protein US9. PLoS ONE 9:e104634. https://doi.org/10.1371/journal.pone.0104634 · DOI
- Sengupta R, Burbassi S, Shimizu S et al (2009) Morphine increases brain levels of ferritin heavy chain leading to inhibition of CXCR4-mediated survival signaling in neurons. J Neurosci 29:2534–2544. https://doi.org/10.1523/JNEUROSCI.5865-08.2009 · DOI
- Nash B, Tarn K, Irollo E et al (2019) Morphine-induced modulation of endolysosomal iron mediates upregulation of ferritin heavy chain in cortical neurons. eNeuro 6. https://doi.org/10.1523/ENEURO.0237-19.2019 · DOI
- Festa LK, Irollo E, Platt BJ et al (2020) CXCL12-induced rescue of cortical dendritic spines and cognitive flexibility. eLife 9:e49717. https://doi.org/10.7554/eLife.49717 · DOI
- Schindelin J, Arganda-Carreras I, Frise E et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676–682. https://doi.org/10.1038/nmeth.2019 · DOI · Paper page
- Liu C, Xu P, Lamouille S et al (2009) TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling. Mol Cell 35:26–36. https://doi.org/10.1016/j.molcel.2009.06.018 · DOI · Paper page
- Mullan M, Crawford F, Axelman K et al (1992) A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N–terminus of β–amyloid. Nat Genet 1:345–347. https://doi.org/10.1038/ng0892-345 · DOI · Paper page
- Brideau AD, del Rio T, Wolffe EJ, Enquist LW (1999) Intracellular trafficking and localization of the pseudorabies virus Us9 type II envelope protein to host and viral membranes. J Virol 73:4372–4384 · DOI
- Miller CCJ, McLoughlin DM, Lau K-F et al (2006) The X11 proteins, abeta production and Alzheimer’s disease. Trends Neurosci 29:280–285. https://doi.org/10.1016/j.tins.2006.03.001 · DOI · Paper page
- Margolis B, Borg J-P, Straight S, Meyer D (1999) The function of PTB domain proteins. Kidney Int 56:1230–1237. https://doi.org/10.1046/j.1523-1755.1999.00700.x · DOI · Paper page
- Seegar TCM, Killingsworth LB, Saha N et al (2017) Structural basis for regulated proteolysis by the α-secretase ADAM10. Cell 171:1638-1648.e7. https://doi.org/10.1016/j.cell.2017.11.014 · DOI · Paper page
- Koo EH, Squazzo SL, Selkoe DJ, Koo CH (1996) Trafficking of cell-surface amyloid beta-protein precursor. I. Secretion, endocytosis and recycling as detected by labeled monoclonal antibody. J Cell Sci 109(Pt 5):991–998 · DOI · Paper page
- Ulery PG, Beers J, Mikhailenko I et al (2000) Modulation of β-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP): evidence that lrp contributes to the pathogenesis of Alzheimer’s disease *. J Biol Chem 275:7410–7415. https://doi.org/10.1074/jbc.275.10.7410 · DOI · Paper page
- Lee M-S, Kao S-C, Lemere CA et al (2003) APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol 163:83–95. https://doi.org/10.1083/jcb.200301115 · DOI · Paper page
- Zhang T, Chen D, Lee TH (2020) Phosphorylation signaling in APP processing in Alzheimer’s disease. Int J Mol Sci 21:209. https://doi.org/10.3390/ijms21010209 · DOI
- Lombino F, Biundo F, Tamayev R et al (2013) An intracellular threonine of amyloid-β precursor protein mediates synaptic plasticity deficits and memory loss. PLoS ONE 8:e57120. https://doi.org/10.1371/journal.pone.0057120 · DOI · Paper page
- Foidl BM, Humpel C (2018) Differential hyperphosphorylation of tau-S199, -T231 and -S396 in organotypic brain slices of Alzheimer mice. A model to study early tau hyperphosphorylation using okadaic acid. Front Aging Neurosci 10:113. https://doi.org/10.3389/fnagi.2018.00113 · DOI
- Luna-Viramontes NI, Campa-Córdoba BB, Ontiveros-Torres MÁ et al (2020) PHF-core tau as the potential initiating event for tau pathology in Alzheimer’s disease. Front Cell Neurosci 14:247. https://doi.org/10.3389/fncel.2020.00247 · DOI
- Zheng H, Koo EH (2011) Biology and pathophysiology of the amyloid precursor protein. Mol Neurodegener 6:27. https://doi.org/10.1186/1750-1326-6-27 · DOI · Paper page
- Tapia-Rojas C, Cabezas-Opazo F, Deaton CA et al (2018) It’s all about tau. Prog Neurobiol. https://doi.org/10.1016/j.pneurobio.2018.12.005 · DOI · Paper page
- Deng J, Habib A, Obregon DF et al (2015) Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3β signaling pathway. J Neurochem 135:630–637. https://doi.org/10.1111/jnc.13351 · DOI
- Bell KFS, Zheng L, Fahrenholz F, Cuello AC (2008) ADAM-10 over-expression increases cortical synaptogenesis. Neurobiol Aging 29:554–565. https://doi.org/10.1016/j.neurobiolaging.2006.11.004 · DOI
- Richter MC, Ludewig S, Winschel A et al (2018) Distinct in vivo roles of secreted APP ectodomain variants APPsα and APPsβ in regulation of spine density, synaptic plasticity, and cognition. EMBO J 37:e98335. https://doi.org/10.15252/embj.201798335 · DOI
Cited by
Wang, J., Fourriere, L., & Gleeson, P. A. (2024) · Biochemical Journal · doi:10.1042/bcj20240056 · Cited by 27
Metadata
- Authors
- Brandimarti, R., Irollo, E., & Meucci, O.
- Venue
- Molecular Neurobiology
- Published
- 2022-12-28
- Volume
- 60
- Issue
- 4
- Pages
- 1811-1825
- ISSN
- 0893-7648
- 1559-1182
- Cited by
- 3
- References
- 19
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- Center for Scientific Review (DA032444, DA040519, DA015014)
- Ministero dell’Istruzione, dell’Università e della Ricerca (RFO2017)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The US9-Derived Protein gPTB9TM Modulates APP Processing Without Targeting Secretase Activities. https://app.cochat.ai/papers/10.1007/s12035-022-03153-2
- The paper
- Brandimarti, R., Irollo, E., & Meucci, O. (2023). The US9-Derived Protein gPTB9TM Modulates APP Processing Without Targeting Secretase Activities. Molecular Neurobiology. https://doi.org/10.1007/s12035-022-03153-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.